NCT05190263View on ClinicalTrials.gov

Quality Assurance on Anemia Management in Patients With Solid Tumors and Malignant Lymphoma

CompletedOBSERVATIONAL
Enrollment

1,053

Participants

Timeline

Start Date

October 25, 2021

Primary Completion Date

February 6, 2022

Study Completion Date

February 6, 2022

Conditions
Anemia, Iron DeficiencySolid TumorMalignant Lymphoma
Interventions
OTHER

non-interventional retrospective epidemiological observational study

non-interventional retrospective epidemiological observational study

Trial Locations (1)

67661

Studienzentrum Prof. Dr. med. Hartmut Link, Facharzt für Innere Medizin, Hämatologie und Internistische Onkologie, Kaiserslautern

All Listed Sponsors
collaborator

Prof. Hartmut Link

UNKNOWN

collaborator

MMF GmbH

INDUSTRY

collaborator

AIO AG Supportivtherapie

OTHER

collaborator

AG Supportive Maßnahmen in der Onkologie

OTHER

lead

AIO-Studien-gGmbH

OTHER

NCT05190263 - Quality Assurance on Anemia Management in Patients With Solid Tumors and Malignant Lymphoma | Biotech Hunter | Biotech Hunter